Progress in herpes simplex virus type 2 vaccine research
LIU Lei, LI Qihan
Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China
Abstract：Herpes simplex virus type 2 (HSV-2) is a member of the alpha subgroup of the human herpes virus family. It has a strong pathogenic ability to cause genital herpes and other herpes diseases in various age groups. Due to its complex genetic structure and pathological features, there is no effective clinical treatment for this medical concern. In addition, latent infection of nerve system, viral reactivation and viral induced immune suppression are major challengers for vaccine research and development.
柳蕾，李琦涵. 单纯疱疹病毒2型疫苗的研究进展[J]. 微生物与感染, 2019, 14(4): 246-251.
LIU Lei, LI Qihan. Progress in herpes simplex virus type 2 vaccine research. JOURNAL OF MICROBES AND INFECTIONS, 2019, 14(4): 246-251.
2019, Vol. 14 
